Clusterin antibody (AA 150-300)
Quick Overview for Clusterin antibody (AA 150-300) (ABIN7126231)
Target
See all Clusterin (CLU) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 150-300
 - 
                                            
Specificity
 - Clusterin, also designated complement lysis inhibitor (CLI), apolipoprotein J (APOJ), sulfated glycoprotein 2 (SGP2), SP40 and testosterone-repressed prostate message 2 (TRPM2), is a secretory, heterodimeric glycoprotein that influences immune regulation, cell adhesion, transformation, lipid transportation, tissue remodeling, membrane recycling and cell-cell interactions. Clusterin is synthesized as a 449 amino acid polypeptide that is post-translationally cleaved at an internal bond between Arg 227 and Ser 228. Two subunits, i± and i², are associated through disulfide bonds. The i² subunit (also called ApoJi±) corresponds to residues 23-227. The i± subunit (also called ApoJi²) corresponds to residues 228-449. Overexpression of Clusterin appears to be more common in late stages of mammary tumor progression. Clusterin markedly influences i²-Amyloid structure and neuritic toxicity in vivo and may influence Alzheimer s pathogenesis.
 - 
                                            
Cross-Reactivity (Details)
 - Human.
 - 
                                            
Purification
 - 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
 - 
                                            
Immunogen
 - Recombinant fragment (around aa150-300) of human CLU protein (exact sequence is proprietary)
 - 
                                            
Isotype
 - IgG2b
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - 
                        
Known_Application: Western Blot (2-4 μg/mL), ,Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.
Positive_Control: Human pancreas, tonsil or cervix.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Concentration
 - 1.0 mg/mL
 - 
                                            
Buffer
 - Prepared in 10 mM PBS, WITHOUT BSA and Azide.
 - 
                                            
Preservative
 - Azide free
 - 
                                            
Storage
 - -20 °C,-80 °C
 - 
                                            
Storage Comment
 - Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
 - 
                                            
Expiry Date
 - 24 months
 
 - 
                                            
 - 
    
- Clusterin (CLU)
 - 
                                            
Alternative Name
 - CLU
 - 
                                            
Background
 - 
                        Aging associated protein 4, Apolipoprotein J, CLU1, CLU2, Clusterin alpha / beta chain, Complement associated protein SP40, Complement cytolysis inhibitor a chain, NA1/NA2, D14Ucla3, Dimeric acid glycoprotein, GP80, Ku70-binding protein 1 (KUB1), Sulfated glycoprotein 2 (SGP2), Testosterone repressed prostate message 2 (TPRM2B),Clusterin / Apolipoprotein J (APO-J)
Cellular localisation: Secreted. Can retrotranslocate from secretory compartments to cytosol upon cellular stress and Nucleus. Cytoplasm. Mitochondrion membrane. Cytoplasm, cytosol. Microsome. Endoplasmic reticulum. Cytopla - 
                                            
Molecular Weight
 - 70kDa (precursor), 36-39kDa (i±), 34-36kDa (i²)
 - 
                                            
Gene ID
 - 1191, 436657
 - 
                                            
UniProt
 - P10909
 - 
                                            
Pathways
 - Apoptosis, Negative Regulation of intrinsic apoptotic Signaling
 
Target
 -